Tuesday, March 5, 2024 Mar 5, 2024
72° F Dallas, TX

COVID-19 Bulletin (11/17/21)

Texas joins efforts to fight federal vaccine mandate. Pfizer says other companies can make it COVID-19 pill.
By |
Courtesy: iStock

Dallas County Judge Clay Jenkins reported a three-day total of 820 new cases and 14 deaths from COVID-19 on Tuesday.

Texas Attorney General Ken Paxton files lawsuit against vaccine mandate for healthcare workers, KERA reports.  The lawsuit filed Nov. 15 challenges the required vaccination of health care workers’ at facilities receiving federal funding from Medicare or Medicaid by Jan. 4.

Pfizer agrees to let other companies make its experimental COVID-19 pill, The Dallas Morning News Reports. Pfizer says it would grant a license for the antiviral pill to Medicines Patent Pool. This agreement would allow generic drug companies to produce the pill for use in 95 countries, 53% of the world’s population. Pfizer says its pill cuts the risk of hospitalization and death by 90% in people with mild to moderate coronavirus infections.

Gov. Abbott challenges the OSHA COVID-19 vaccine-or-test mandate, WFAA reports. Gov. Greg Abbott files petition in the U.S. Court of Appeals for the Fifth Circuit challenging the Occupational Safety and Health Administration (OSHA) COVID-19 vaccine-or-test mandate. The OSHA mandate will require companies with over 100 employees to ensure their workers are vaccinated or undergo weekly testing. Violations start on Jan. 4 and consist of fines up to $1000.

Related Articles


New Communities Foundation of Texas Leader Wayne White Is All in for the Community

The CEO brings extensive corporate and nonprofit experience to his new role at the helm of the social impact organization.
Executive Travel

On the Road: A Weekend at JW Marriott San Antonio Hill Country and TPC San Antonio

The family-friendly resort, situated on 600 acres of rolling South Texas hills, boasts a waterpark, two pristine golf courses, and fare to remember.
Commercial Real Estate

CBRE Sues Chris Hipps, Claims Breach of Noncompete for Move to Cushman & Wakefield

Along with putting its longtime executive "in the garden" for up to two years, CBRE is seeking as much as $1 million in relief.